Five poster presentations highlight clinical advancement of neffy , real-world usability and advantages of needle-free epinephrine ...
Neffy needle-free epinephrine spray sales surge, global expansion, and CSU Phase 2b upside. See more on SPRY here.
Krystal Biotech (NASDAQ: KRYS) and ARS Pharmaceuticals (NASDAQ: SPRY) have been gaining a lot of attention over the past year ...
The Oregon Senate has unanimously passed Senate Bill 1504, aiming to enhance emergency response to allergic reactions in ...
Five poster presentations highlight clinical advancement of neffy, real-world usability and advantages of needle-free epinephrine delivery -Longer shelf life of nasal epinephrine compared with ...
4don MSNOpinion
Opinion: A good place to start Trump’s new health care plan: More drugs over the counter
The FDA should make more safe drugs available for over-the-counter purchase, starting with albuterol, in order to reduce ...
Nasus Pharma Ltd. (NYSE: NSRX) ("Nasus Pharma" or the "Company"), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products, today announced the closing of ...
Melbourne, 16 February 2026CSL Seqirus, part of leading Australian biotechnology company CSL, has today announced that neffy® adrenaline (epinephrine ...
Nasus Pharma Ltd. (NYSE: NSRX) shares went lower Friday. The Tel Aviv-based company, a clinical-stage pharmaceutical firm focused on the development of innovative intranasal products, today announced ...
Background Drug exposure has been reported in association with Takotsubo syndrome, but the breadth and relative strength of ...
Nasus Pharma Ltd. (NYSE: NSRX) ("Nasus Pharma" or the "Company"), a clinical-stage pharmaceutical company focused on the development of innovative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results